Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Chromosome Disorders

• MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
• Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
• A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism
• Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS
• An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)
• Growth Hormone Treatment in Children With Phelan McDermid Syndrome
• A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
• AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy
• A Trial of Metformin in Individuals With Fragile X Syndrome
• Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy
• Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome
• Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
• Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities
• Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
• Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality
• Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality